Sponsored Links / Ads

Prostate Cancer

Recent Prostate Cancer News
Obesity significantly increases prostate cancer risk in African-American men, study finds

April 16, 2015 Obesity has a profoundly different effect on prostate cancer risk in African-American as compared to non-Hispanic white men.... [via Fred Hutchinson Cancer Research Center]

Active Surveillance of Intermediate-Risk Prostate Cancer Associated With Decreased Survival | ASCO.org

An analysis of data on 945 patients with prostate cancer that is managed with active surveillance shows differences in outcomes depending on whether the patient was low or intermediate risk at ... [via ASCO]

Men Who Have Had Testicular Cancer Are More Likely to Develop Prostate Cancer, Although Overall Risk of Developing Aggressive Disease is Low | ASCO.org

A case-control study of close to 180,000 men suggests that the incidence of prostate cancer is higher among men with a history of testicular cancer than among those without a history of testicular ... [via ASCO]

Early Evidence of Increase in Higher-Risk Prostate Cancers From 2011-2013 | ASCO.org

An analysis of data on roughly 87,500 men treated for prostate cancer since 2005 finds a notable increase in higher-risk cases of the disease between 2011 and 2013.... [via ASCO]

Androgen Receptor Abnormality May Not Be Associated With Primary Resistance to Taxane Chemotherapy | ASCO.org

Findings from a small prospective study suggest that androgen receptor V7 status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate ... [via ASCO]

ASCO Endorses American Cancer Society Prostate Cancer Survivorship Care Guidelines | ASCO.org

The American Society of Clinical Oncology today issued an endorsement of the American Cancer Societys Prostate Cancer Survivorship Care Guidelines.... [via ASCO]

Rejected prostate cancer drug 'extends life'

For a better experience on your device, try our mobile site. The drug abiraterone can add four months to the lives of men with advanced prostate cancer if given before chemotherapy, evidence suggests.... [via BBC]

Nymox Drug for Enlarged Prostate Doesnt Meet Targets

Nymox Pharmaceutical Corp. said studies for its drug to treat prostate enlargement didnt produce intended results.... [via Bloomberg]

Silicon Valley Billionaire Creating Prostate Cancer Test

Close Silicon Valley real estate billionaire Carl Berg thinks hes found a better prostate cancer test and is investing hundreds of millions of dollars to bring it to market.... [via Bloomberg]

Cancer patient on how Abiraterone has helped his treatment

For a better experience on your device, try our mobile site.... [via BBC]

NICE defends decision on prostrate drug Abiraterone

For a better experience on your device, try our mobile site.... [via BBC]

Certain Form of Baldness at Age 45 Linked to Higher Risk of Aggressive Prostate Cancer | ASCO.org

In this News Digest: A new, large cohort analysis from the prospective Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, indicates that men who had moderate baldness affecting both the ... [via ASCO]

U.S. FDA okays expanded use of Medivation prostate cancer drug

U.S. health regulators approved the use of Medivation Inc's advanced prostate cancer drug Xtandi in men who have not yet received chemotherapy, the company said on Wednesday, significantly expanding ... [via Reuters]

ASCO and Cancer Care Ontario Issue New Guideline on Treating Metastatic Castration-Resistant Prostate Cancer | ASCO.org

The American Society of Clinical Oncology and Cancer Care Ontario today issued a joint clinical practice guideline on treating men with metastatic castration-resistant prostate cancer .... [via ASCO]

Too Many Cancer Screenings Wasted on Those Facing Death

Older patients who arent expected to live more than another decade are still being screened too often for cancers, causing more harm than good, a study found.... [via Bloomberg]

Featured Prostate Cancer Articles

 Books related to prostate cancer treatment, prevention, screening, survival and support.... [more]

Prostate Cancer Diagnosis: Do you need a second Opinion?  
 When a patient receives news of what their biopsy showed, there may be several misconceptions. First, you as the the patient may assume that the surgeon who performed the biopsy was also the person wh... [more]

Prostate Cancer Screening: The United States Preventive Services Task Force Draft recommendation 
  "Whereas the USPSTF previously recommended against PSA-based screening for prostate cancer in men aged 75 years and older and concluded that the evidence was insufficient to make a recommendation in ... [more]

 Intensity Modulated Radiation Therapy (IMRT) is valuable for reducing toxiciy of radiation treatment for prostate cancer. The principle of IMRT involves using hundred of small beams at variable intens... [more]

 A low-fat diet with fish oil supplements eaten for four to six weeks prior to prostate removal slowed down the growth of prostate cancer cells – the number of rapidly dividing cells– in human prostate... [more]

 A long-term study by researchers at UCLA’s Jonsson Comprehensive Cancer Center found that the three most common treatments for localized prostate cancer had significant impacts on patients’ quality of... [more]

 Initial results of a multicenter study indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to be aggressive and potentially life-threatening ... [more]

Effective drug to prevent prostate cancer does not interfere with sexual function for most men 
 ANN ARBOR, Mich - Men and their physicians need not hesitate to use a drug proven effective in preventing prostate cancer out of concern that it is likely to cause sexual dysfunction, say authors of a... [more]

Prostate Cancer: Questions & Answers 
 All men are at risk. The most common risk factor is age. More than 70 percent of men diagnosed with prostate cancer each year are over the age of 65. African American men have a higher risk of prostat... [more]

Vasectomy and Cancer Risk: Is There an Increased Risk of Prostate Cancer? 
 Some studies have raised questions about a possible relationship between vasectomy (an operation to cut or tie off the two tubes that carry sperm out of the testicles) and the risk of developing cance... [more]

Predicting the Outcome of the Random Prostate Biopsy 
 The diagnosis of prostate cancer depends upon prostate biopsy. While abnormal digital rectal exam (DRE) and Prostate Specific Antigen (PSA) are indications for biopsy they provide limited predictive p... [more]

Selenium intake may worsen prostate cancer in some, study reports 
 Higher selenium levels in the blood may worsen prostate cancer in some men who already have the disease, according to a study by researchers at Dana-Farber Cancer Institute and the University of Calif... [more]

Reducing Intake of Dietary Fat Prevents Prostate Cancer in Mice  
 Scientists with UCLA’s Jonsson Cancer Center and the Department of Urology have shown that lowering intake of the type of fat common in a Western diet helps prevent prostate cancer in mice, the first ... [more]

Prostate Cancer: UCLA Scientists Identify a Cell of Origin for Human Prostate Cancer 
  UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and... [more]

Treatment for Early Prostate Cancer Associated with Type of Specialist Seen 
 CHICAGO - A new study analyzing men with localized prostate cancer shows that the specialty of the physician they see can influence the type of therapy they ultimately receive. ... [more]

Prostate Cancer Research: Study Examines Quality of Life After Common Treatments for Prostate Cancer 
 A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways.... [more]


These review articles are the opinions of the authors. Some of the views may be controversial. CancerNews.com™ does not directly endorse the work. We merely present it as part of our service. Please read the disclaimer.

This site is property of Net Ventures, Inc.